N/A Completed N=1 Treatment

Intravesical Liposomes for Ulcerative Cystitis

Interstitial Cystitis

Source: ClinicalTrials.gov NCT01083979 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Feb 2017

Primary outcomePrimary: Change in Symptom and Problem Severity — 22; 13 units on a scale

Summary

The objective is to instill liposomes reconstituted with sterile water into the bladder as a compassionate use treatment in one patient with ulcerative interstitial cystitis (IC).

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Symptom and Problem Severity	22; 13	—
SECONDARY Bladder Appearance	3; 0	—

Eligibility Criteria

Inclusion Criteria

Ulcerative IC for at least 6 months documented,
Negative urine cytology,
Able to independently complete self administered questionnaires and voiding diaries.

Exclusion Criteria

Pregnant or lactating,
History of bleeding diathesis,
On anticoagulant therapy,
Active peptic ulcer disease,
Obvious neurological impairment,
Known allergy to liposomes.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01083979). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.